Pages that link to "Item:Q827694"
From MaRDI portal
The following pages link to Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer (Q827694):
Displaying 2 items.
The following pages link to Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer (Q827694):
Displaying 2 items.